CTLA4 and neoplasm: At the same time, the expression levels of cytokines and immunosuppressor molecules (PD1, PD-L1, PD-L2, CTLA4, TIGIT, TIM-3, BTLA, and LAG3) were significantly higher in low-risk groups, implying more tumor immunogenicity in the low-risk group.